Vol 36, (3) 97-192
Pap test update
Stella Heley BA(Hons), MBBS, FAChSHM, is a sexual
health physician, Melbourne Sexual Health Centre, and Senior Liaison
Physician, Victorian Cytology
Service
BACKGROUND 2006 was an eventful year in the area of screening to prevent cervical cancer. New screening guidelines were introduced nationally in July, and in November the Australian Government agreed to fund one of the human papillomavirus (HPV) vaccines, Gardasil, under the National Immunisation Program.
OBJECTIVE This article discusses the cervical screening program and the Pap test in the era of HPV vaccination.
DISCUSSION With the introduction of a vaccine to prevent the acquisition of significant genital HPV types, many practitioners will be questioning the continuing need for the Pap test. But for those women who have missed out on the vaccine, the Pap test will still play a crucial role in preventing the development of cervical cancer, and the vaccinated cohort will need to continue screening in some form as the vaccine does not cover all the HPV types responsible for anogenital cancer.
Related files
To download files on a PC: Right click the link and select 'Save Target As'.
To download files on a Mac: Hold Ctrl, click the link and select 'Download link to disk'.
Help with viewing files
Related links
AFP Audio: Interview with Dr Stella Heley
The RACGP is not responsible for and does not necessarily endorse content on external sites.
